EU Roll out begins for Defitelio

Published on 02 April 2014

EU Roll out begins for Defitelio

Jazz Pharmaceuticals has commenced the EU roll out of it's rare liver disease drug Defitelio, assisted by Pinnaculum in the management and preparation of it's pan-european launch artwork. 

Pinnaculum have assisted in developing a livery design, preparing regulatory submission artwork, with the manufacturing site and preparation of launch artwork across the SKU range. The full launch is planned to include all 27 EU countries over the next 18 months to 2 years.

Read a full article on the Defitelio launch on the Pharma Times

Back to April Listings